![](/img/cover-not-exists.png)
Synthetic Lethality Exploitation by an Anti–Trop-2-SN-38 Antibody–Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2 –wild-type Triple-Negative Breast Cancer
Cardillo, Thomas M., Sharkey, Robert M., Rossi, Diane L., Arrojo, Roberto, Mostafa, Ali A., Goldenberg, David M.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-2401
Date:
January, 2017
File:
PDF, 1.82 MB
english, 2017